HF
ALIM

HRT Financial’s Alimera Sciences ALIM Stock Holding History

HRT Financial’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-25,586
Closed -$99K – 3323
2024
Q1 		$99K Buy
+25,586
New +$97.4K ﹤0.01% 1855

Other funds holding ALIM

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

HRT Financial's ALIM Position: Q2 2024 in Review

HRT Financial sold out of Alimera Sciences (ALIM) in Q2 2024, closing a stake of 25,586 shares — an estimated $99K sold.

HRT Financial first reported a position in ALIM in Q1 2024 and held it in 1 quarter. The position peaked at $99K in Q1 2024. 52 funds tracked by Wall St. Rank hold ALIM as of Q2 2024.

  • HRT Financial reported no remaining Alimera Sciences position as of Q2 2024 after selling out during the quarter.
  • HRT Financial sold 25,586 Alimera Sciences shares in Q2 2024, an estimated $99K.
  • HRT Financial first reported a position in Alimera Sciences in Q1 2024 and held it in 1 quarter.
  • HRT Financial's Alimera Sciences position peaked at $99K in Q1 2024.
  • 52 funds tracked by Wall St. Rank held Alimera Sciences as of Q2 2024.

Based on HRT Financial's 13F filing for Q2 2024, filed 12 Aug 2024.